COMPLETED

PREVENT Pilot HPV - Related Cancers Trial

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States. The proposed study will assess the feasibility of clinic-based outreach to increase vaccination rates for HPV at four community clinics in rural counties in Washington.

Official Title

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - Pilot Trial

Quick Facts

Study Start:2025-05-20

Study Completion:2025-08-12

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT06738355

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Parents/Caregivers (P/C) of children/adolescents (C/A) ages 9-17 years of age (i.e., age-eligible for HPV vaccination); 2. P/C with active clinic patients (i.e., have been seen in the clinic in the last 12 months); and 3. P/C who speak either English or Spanish.	1. P/C of C/A with previous excluding HPV vaccination history (e.g., completed vaccination, or not due); 2. P/C of C/A with clinical conditions that influence the CDC HPV vaccination recommendations (e.g., pregnancy); 3. P/C of C/A with other factors that would influence CDC HPV recommendations; and 4. P/C that does not speak Spanish or English.

Contacts and Locations

Principal Investigator

Deanna Kepka, PhD, MPH

PRINCIPAL_INVESTIGATOR

Study Principal Investigator

Study Locations (Sites)

Sea Mar Community Health Centers

Seattle, Washington, 98108

United States

Collaborators and Investigators

Sponsor: University of Utah

Deanna Kepka, PhD, MPH, PRINCIPAL_INVESTIGATOR, Study Principal Investigator

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-20

Study Completion Date2025-08-12

Study Record Updates